Literature DB >> 11965550

The putative ovarian tumour marker gene HE4 (WFDC2), is expressed in normal tissues and undergoes complex alternative splicing to yield multiple protein isoforms.

Lynne Bingle1, Vanessa Singleton, Colin D Bingle.   

Abstract

The whey acidic protein (WAP) domain is a conserved motif, containing eight cysteines found in a characteristic 4-disulphide core arrangement, that is present in a number of otherwise unrelated proteins. WAP motifs are present in SLPI and elafin, two antiproteinases located on chromosome 20q12-13, in a locus rich in poorly characterized WAP domain proteins. One of these proteins, which contains two WAP domains, is HE4 (also known as WFDC2), originally described as an epididymis specific protein but more recently suggested to be a putative serum tumour marker for ovarian cancer. We have shown that HE4 is expressed in a number of normal human tissues outside of the male reproductive system, including regions of the respiratory tract and nasopharynx, as well as in a subset of lung tumour cell lines. Comparison of multiple HE4 cDNAs and RT-PCR products with genomic sequence allowed the elucidation of the genomic organization. These studies revealed that HE4 can undergo a complex series of alternative splicing events that can potentially yield five distinct WAP domain containing protein isoforms. These results cast doubt on the potential role of HE4 as a serum tumour marker specific for ovarian cancer and open the door to understanding the function of multiple WAP domain containing protein isoforms arising from a single gene.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11965550     DOI: 10.1038/sj.onc.1205363

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  70 in total

Review 1.  The comparative biology of whey proteins.

Authors:  Kaylene J Simpson; Kevin R Nicholas
Journal:  J Mammary Gland Biol Neoplasia       Date:  2002-07       Impact factor: 2.673

2.  Role of HE4, CA72.4, and CA125 in monitoring ovarian cancer.

Authors:  Teresa Granato; Cecilia Midulla; Flavia Longo; Barbara Colaprisca; Luigi Frati; Emanuela Anastasi
Journal:  Tumour Biol       Date:  2012-04-13

3.  Use of a human embryonic stem cell model to discover GABRP, WFDC2, VTCN1 and ACTC1 as markers of early first trimester human trophoblast.

Authors:  Rowan M Karvas; Samuel McInturf; Jie Zhou; Toshihiko Ezashi; Danny J Schust; R Michael Roberts; Laura C Schulz
Journal:  Mol Hum Reprod       Date:  2020-06-01       Impact factor: 4.025

4.  Serum HE4 is more suitable as a biomarker than CA125 in Chinese women with benign gynecologic disorders.

Authors:  Yan Zhang; Chunxia Qiao; Lian Li; Xuye Zhao; Yali Li
Journal:  Afr Health Sci       Date:  2014-12       Impact factor: 0.927

5.  Voxelwise genome-wide association study (vGWAS).

Authors:  Jason L Stein; Xue Hua; Suh Lee; April J Ho; Alex D Leow; Arthur W Toga; Andrew J Saykin; Li Shen; Tatiana Foroud; Nathan Pankratz; Matthew J Huentelman; David W Craig; Jill D Gerber; April N Allen; Jason J Corneveaux; Bryan M Dechairo; Steven G Potkin; Michael W Weiner; Paul Thompson
Journal:  Neuroimage       Date:  2010-02-17       Impact factor: 6.556

6.  Splice variant HE4-V3 expression is associated with favorable prognosis in pulmonary adenocarcinoma.

Authors:  Keita Tokuishi; Shin-ichi Yamashita; Kazuyuki Ohbo; Katsunobu Kawahara
Journal:  Tumour Biol       Date:  2011-10-21

Review 7.  Recent advancements in fabrication of nanomaterial based biosensors for diagnosis of ovarian cancer: a comprehensive review.

Authors:  Rinky Sha; Sushmee Badhulika
Journal:  Mikrochim Acta       Date:  2020-02-19       Impact factor: 5.833

8.  Paracrine SLPI secretion upregulates MMP-9 transcription and secretion in ovarian cancer cells.

Authors:  Ebony Hoskins; Jaime Rodriguez-Canales; Stephen M Hewitt; Wafic Elmasri; Jasmine Han; Shing Han; Ben Davidson; Elise C Kohn
Journal:  Gynecol Oncol       Date:  2011-06-14       Impact factor: 5.482

9.  HE4: a new potential early biomarker for the recurrence of ovarian cancer.

Authors:  Emanuela Anastasi; Giulia Giovanna Marchei; Valentina Viggiani; Giuseppina Gennarini; Luigi Frati; Maria Gabriella Reale
Journal:  Tumour Biol       Date:  2010-01-23

10.  Human epididymis protein 4 is a biomarker for transitional cell carcinoma in the urinary system.

Authors:  Zhu Xi; Ma LinLin; Tian Ye
Journal:  J Clin Lab Anal       Date:  2009       Impact factor: 2.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.